JAKARTA, investor.id – Bio-Tech company PT Natura Nuswantara Nirmala (Nucleus Farma) has successfully obtained patents for two of its inventions from the Directorate General of Intellectual Property of the Ministry of Law and Human Rights.
“We are very happy and proud of the release of these two patents in early 2022. This is a gift for us and the Indonesian people in general who are consumers of Nucleus Farma’s quality products,” said CEO Supahabu Samuel Wirjawan in a written statement, Friday (11/11). /2). Supahabu is an affiliate and licensee of the Nucleus Farma group.
Selengkapnya : https://investor.id/business/282382/nucleus-farma-kantongi-dua-hak-paten-sekaligus-di-awal-2022
